Valganciclovir for symptomatic congenital cytomegalovirus disease - Wikidata - awgldk - TriplyDB

Valganciclovir for symptomatic congenital cytomegalovirus disease

Valganciclovir for symptomatic congenital cytomegalovirus disease

http://www.wikidata.org/entity/Q35465712

about

Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children Pregnancy Outcomes of Mothers with Detectable CMV-Specific IgM Antibodies: A Three-Year Review in a Large Irish Tertiary Referral Maternity Hospital Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes Approved Antiviral Drugs over the Past 50 Years Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus Cytomegalovirus infection in pregnancy Follow-up of infants with congenital cytomegalovirus and normal fetal imaging.Symptomatic Postnatal Cytomegalovirus Testing among Very Low-Birth-Weight Infants: Indications and Outcomes.Persistent intestinal bleeding due to severe CMV-related thrombocytopenia in a preterm newborn.Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment Symptomatic Congenital Cytomegalovirus Infection in Children of Seropositive Women Asymmetric and unilateral hearing loss in children Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women, in Montreal, Canada Burden of respiratory tract infections at post mortem in Zambian children.Effect of artemether-lumefantrine (Coartem) on cytomegalovirus urine viral load during and following treatment for malaria in children.Advances in the prevention and treatment of congenital cytomegalovirus infection Why CMV is a candidate for elimination and then eradication.A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.Cytomegalovirus in pregnancy and the neonate.Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.Anti-viral therapy for congenital cytomegalovirus infection: pharmacokinetics, efficacy and side effects.Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.Pharmacokinetic considerations in the use of antivirals in neonates.Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature.Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.Congenital cytomegalovirus infection in Central Germany: an underestimated risk.Optimum treatment of congenital cytomegalovirus infection.Association of cognitive function and liability to addiction with childhood herpesvirus infections: A prospective cohort study.Congenital and perinatally-acquired infections in resource-constrained settings.Treatment of perinatal viral infections to improve neurologic outcomes.Positive IgM in Congenital CMV Infection.Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis.Hearing outcome of infants with congenital cytomegalovirus and hearing impairment.Severe neonatal cytomegalovirus infection: about a case.Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.Preventing Congenital Cytomegalovirus Infection.Sensorineural Hearing Loss in a Patient Affected by Congenital Cytomegalovirus Infection: Is It Useful to Identify Comorbid Pathologies?International opinions and national surveillance suggest insufficient consensus regarding the recognition and management practices of infants with congenital cytomegalovirus infections.PCR tests for uterine cervical secretion are promising noninvasive methods for predicting congenital cytomegalovirus infection.

P2860

Q26742161-3BF048F5-1451-44A2-BD83-945FC2869FDD Q26773186-E5E92061-04B6-4C83-9E7B-E082D3F83EE7 Q27010776-BAEEB500-E872-4834-B66D-2F77BF05342E Q27755387-B265E91D-A341-433B-9B66-31F99F460385 Q28552095-B108A663-532E-4A9C-ADCA-2996C5FEB934 Q29994481-C9DDB2D5-965E-4B90-A9D5-7E4CAF071026 Q33429331-ABF04A0A-34D4-4977-AC88-BD93D1F63503 Q33431331-C6A7EBF9-8FCD-42B8-9007-B8645A35B167 Q33440843-8CE43480-E7E9-4591-932D-C4BA17E7741A Q33568646-C2A2E56E-7627-4FD1-9113-820695B3BCD2 Q33780561-DED443A5-4CB1-47EE-B504-DE01FFDB8DCF Q35811983-6638B1BD-9339-474D-B631-08535EBE584D Q35958109-85AF18D8-3D7B-4A2B-AB95-343025EA1A26 Q36065275-842533DA-594D-4E2D-B81A-A8C8987D5B41 Q36689547-287AED7E-6770-4ABE-9D94-BC07E8C97D67 Q37006043-4C5469D8-DFA3-45B1-AB0B-953C0A6320C2 Q37141395-E9709FA7-380B-4224-939C-D73825F91475 Q37182670-24C5CE5D-F11F-4A5E-AFB0-BBC048F463A9 Q37643347-659F947C-D9D6-4527-92BF-80A5AB8C2EAD Q37656015-F9DBE006-8F01-4D08-8E9C-05F99E4B333C Q38541974-D9963F7F-C337-4F5F-95FE-E21AE5A42E7E Q38590590-70F6BABA-76AD-443B-BF0C-D0A7EC998CA6 Q38624965-06573641-2A9E-4E0F-B337-890E223C5D4A Q38667100-5349574A-2DBD-420F-9EF1-03887AF589DE Q38718373-CCE034EB-3EE7-4C98-94C0-45D0DC3FF1D8 Q38720764-7F299EC3-08F4-480B-B481-222584ACD442 Q38797872-B9F71DD9-D92E-4457-9C50-CD8FAED394AB Q38831648-63DBC311-48FF-420F-92CC-E6987DB078F5 Q38904188-EEF1CAC3-1D9C-4E79-AD13-B64124B7AE63 Q38965659-8A5C3FC1-93DE-45D1-A566-95FF1C12BA87 Q39071532-DF79B2BF-19B7-4997-AFAB-393A7D8BCCBF Q39296561-6FB126E2-9A8E-48A8-B799-0B66867CB93B Q39822119-3D944C3C-1926-4BBA-AA39-A7426B7381C3 Q40041718-2CDF4402-046D-4010-97D7-66D09FB8903C Q40047616-152136D0-6954-4B9E-BB1B-985699AB787E Q40074992-822F0B43-F72A-4F66-A453-7D484DC964D0 Q40086042-4CD998F3-50F2-4B70-BC1E-C0CACA03B253 Q40099417-7DE692A3-14D3-474B-9638-E6EFD1368965 Q40246777-F2A49E41-7B52-4D30-B9E2-90875C02F3F8 Q40257543-EF637A03-F028-4D2D-B442-0EBB68850458

P2860

Valganciclovir for symptomatic congenital cytomegalovirus disease

http://www.wikidata.org/entity/Q35465712

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Valganciclovir for symptomatic congenital cytomegalovirus disease

@ast

Valganciclovir for symptomatic congenital cytomegalovirus disease

@en

type

label

Valganciclovir for symptomatic congenital cytomegalovirus disease

@ast

Valganciclovir for symptomatic congenital cytomegalovirus disease

@en

prefLabel

Valganciclovir for symptomatic congenital cytomegalovirus disease

@ast

Valganciclovir for symptomatic congenital cytomegalovirus disease

@en

P1433

Q35465712-E423AE69-9FA0-4E83-AD08-104DE7B3095B

P1476

Q35465712-D8EFD07B-F7DC-4165-B0DB-DDE017A46A23

P2093

Q35465712-03EEA063-99F7-4EC4-AF76-4CE0253E062C

Q35465712-090F3DD6-944F-44C3-A0B1-D8505228765B

Q35465712-105DEB5F-81AC-4E4A-A46D-8F227DF5732E

Q35465712-12D832A3-B3D2-46DF-9C2E-13B7DB9B9720

Q35465712-179AC806-1856-4BC3-A274-8674DF42C0E0

Q35465712-18AEAE87-19B8-4571-BF37-1A64210E859E

Q35465712-1989B609-B109-4C8B-9B65-277EC90759F8

Q35465712-1A12EA4C-4961-4134-AF16-788E33A2AC44

Q35465712-2AA0831D-3EE9-4B3F-92E2-B831F7448695

Q35465712-3591572F-EDA1-40EF-B962-7EB8EED767A6

P2860

Q35465712-1343C329-CCC8-4072-852A-4F4ADA8BDE0E

Q35465712-13AE7446-06EB-4ED0-A4C9-5D99334C14D1

Q35465712-275A8339-E13F-4BE7-ACE1-C6F4766495FF

Q35465712-40C3D433-14C8-489B-A8AB-58EAFB99FC97

Q35465712-4DFC8D97-6209-4613-A024-BD791C00641E

Q35465712-5E2DBB2E-CA4B-4BCF-A892-064BFD30C67C

Q35465712-5F1D0A16-AFED-4EB4-83F5-BA15C3B5379D

Q35465712-5F6DE2FE-E070-4D89-80D4-6EC30E0C7296

Q35465712-691C4258-5F1D-496E-B65C-FC565B80141E

Q35465712-7D13FA6A-39E8-471E-B7E5-AE5F666CF272

P304

Q35465712-B14E124F-2059-4F7F-9786-B02948876A2A

P31

Q35465712-F215885C-BA68-40B8-8362-BB6F82777013

P356

Q35465712-091CB181-B23C-413A-A383-3C853BFA2052

P407

Q35465712-E019B882-9AB1-48B8-8954-A6403F32F1AB

P433

Q35465712-B36337A1-F081-4F86-A7AC-7D80DF707748

P478

Q35465712-3B3F532D-0B15-4504-B75F-C755822FA6AC

P50

Q35465712-67057CA1-13F8-479F-920C-FD8ECB275060

Q35465712-9915C434-ECFC-49E7-B79F-E9B357F04B52

Q35465712-9D220AAC-88A6-4284-81BC-BEFCC9F63A27

Q35465712-E92FF112-5F57-4F5D-9562-E84FCF3B7103

Q35465712-EFB5A145-009D-4A10-A03F-92C3DCF3DBB5

P577

Q35465712-4E9D1847-B1AF-49B5-B017-5B0028982BDE

P698

Q35465712-675C6B08-6D44-4D2E-AA8D-FDBF6E9A3501

P921

Q35465712-381B8793-895A-4996-84A1-123C255EDA21

Q35465712-631360F1-1F7D-41DA-B0F7-044997717825

P932

Q35465712-163D2ACB-CA41-4E84-8467-5FF0C4C64CC1

P356

P1433

The New England Journal of Medicine

P1476

Valganciclovir for symptomatic congenital cytomegalovirus disease

@en

P2093

Adam Finn

http://www.w3.org/2001/XMLSchema#string

Amina Ahmed

http://www.w3.org/2001/XMLSchema#string

Andi L Shane

http://www.w3.org/2001/XMLSchema#string

April Palmer

http://www.w3.org/2001/XMLSchema#string

Benjamin Estrada

http://www.w3.org/2001/XMLSchema#string

Charles R Woods

http://www.w3.org/2001/XMLSchema#string

David W Kimberlin

http://www.w3.org/2001/XMLSchema#string

Diane L Sabo

http://www.w3.org/2001/XMLSchema#string

Dusty Giles

http://www.w3.org/2001/XMLSchema#string

Edward P Acosta

http://www.w3.org/2001/XMLSchema#string

P2860

New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection

Ganciclovir therapy for congenital cytomegalovirus infection in six infants.

Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant.

Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection.

Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.

Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection

Congenital cytomegalovirus infection: clinical outcome

Congenital cytomegalovirus (CMV) infection and hearing deficit.

Newborn hearing screening--a silent revolution.

The "silent" global burden of congenital cytomegalovirus.

P304

933-943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1404599

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

Penelope H. Dennehy

Kari A Simonsen

Natasha B. Halasa

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25738669

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

4401811

http://www.w3.org/2001/XMLSchema#string